MX376112B - Derivados fusionados tricíclicos de 1-(ciclo)alquil piridin-2-ona como compuestos inhibidores de la familia bet de bromodominios, y el uso de los mismos en el tratamiento de trastornos proliferativos o cáncer. - Google Patents
Derivados fusionados tricíclicos de 1-(ciclo)alquil piridin-2-ona como compuestos inhibidores de la familia bet de bromodominios, y el uso de los mismos en el tratamiento de trastornos proliferativos o cáncer.Info
- Publication number
- MX376112B MX376112B MX2017012387A MX2017012387A MX376112B MX 376112 B MX376112 B MX 376112B MX 2017012387 A MX2017012387 A MX 2017012387A MX 2017012387 A MX2017012387 A MX 2017012387A MX 376112 B MX376112 B MX 376112B
- Authority
- MX
- Mexico
- Prior art keywords
- bromodomains
- treatment
- alkylpyridin
- cyclo
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1636CH2015 | 2015-03-30 | ||
| PCT/IN2016/050098 WO2016157221A1 (en) | 2015-03-30 | 2016-03-30 | Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017012387A MX2017012387A (es) | 2018-06-11 |
| MX376112B true MX376112B (es) | 2025-03-07 |
Family
ID=56015058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017012387A MX376112B (es) | 2015-03-30 | 2016-03-30 | Derivados fusionados tricíclicos de 1-(ciclo)alquil piridin-2-ona como compuestos inhibidores de la familia bet de bromodominios, y el uso de los mismos en el tratamiento de trastornos proliferativos o cáncer. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10689390B2 (enExample) |
| EP (1) | EP3277683B1 (enExample) |
| JP (1) | JP6764877B2 (enExample) |
| KR (1) | KR102588109B1 (enExample) |
| CN (1) | CN107548393B (enExample) |
| AU (1) | AU2016242473B2 (enExample) |
| BR (1) | BR112017020739B1 (enExample) |
| CA (1) | CA2980266C (enExample) |
| DK (1) | DK3277683T3 (enExample) |
| ES (1) | ES2911886T3 (enExample) |
| IL (1) | IL254528B (enExample) |
| MX (1) | MX376112B (enExample) |
| PL (1) | PL3277683T3 (enExample) |
| PT (1) | PT3277683T (enExample) |
| RU (1) | RU2721120C2 (enExample) |
| WO (1) | WO2016157221A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10689395B2 (en) | 2015-09-09 | 2020-06-23 | Jubilant Biosys Limited | Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors |
| CN108069976A (zh) * | 2016-11-10 | 2018-05-25 | 山东罗欣药业集团股份有限公司 | 一种含氮大环类化合物、其制备方法、药物组合物及应用 |
| WO2019214399A1 (zh) * | 2018-05-10 | 2019-11-14 | 罗欣药业(上海)有限公司 | 苯并七元杂环类化合物、其制备方法、药物组合物及应用 |
| CN110172068A (zh) * | 2019-06-05 | 2019-08-27 | 河南龙湖生物技术有限公司 | 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用 |
| US12527741B2 (en) | 2021-06-17 | 2026-01-20 | Wisconsin Alumni Research Foundation | Modular dendron micelles for treatment of pulmonary diseases related to fibrosis and viral infection including COVID-19 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545767A (en) * | 1976-06-30 | 1979-05-16 | Aspro Nicholas Ltd | Isoquinoline derivatives |
| TW200904403A (en) | 2007-04-25 | 2009-02-01 | Daiichi Sankyo Co Ltd | Tricyclic aryl compounds |
| RU2506267C2 (ru) | 2008-03-31 | 2014-02-10 | Дженентек, Инк. | Бензопирановые и бензоксепиновые ингибиторы рi3k и их применение |
| ES2526671T3 (es) | 2010-06-22 | 2015-01-14 | Glaxosmithkline Llc | Compuestos de benzotriazoldiazepina inhibidores de bromodominios |
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| CA2901352A1 (en) * | 2013-02-19 | 2014-08-28 | Bayer Pharma Aktiengesellschaft | Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines |
| CN105026403B (zh) | 2013-03-12 | 2018-05-18 | 艾伯维公司 | 四环布罗莫结构域抑制剂 |
| WO2015018520A1 (en) | 2013-08-06 | 2015-02-12 | Oncoethix Sa | A bet-brd inhibitor represents a novel agent for alk positive anaplastic large cell lymphoma |
| US9814728B2 (en) * | 2013-09-20 | 2017-11-14 | Saint Louis University | Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi) |
-
2016
- 2016-03-30 DK DK16723536.5T patent/DK3277683T3/da active
- 2016-03-30 KR KR1020177031273A patent/KR102588109B1/ko active Active
- 2016-03-30 WO PCT/IN2016/050098 patent/WO2016157221A1/en not_active Ceased
- 2016-03-30 PL PL16723536T patent/PL3277683T3/pl unknown
- 2016-03-30 CA CA2980266A patent/CA2980266C/en active Active
- 2016-03-30 JP JP2017551712A patent/JP6764877B2/ja active Active
- 2016-03-30 RU RU2017135205A patent/RU2721120C2/ru active
- 2016-03-30 BR BR112017020739-7A patent/BR112017020739B1/pt active IP Right Grant
- 2016-03-30 MX MX2017012387A patent/MX376112B/es active IP Right Grant
- 2016-03-30 EP EP16723536.5A patent/EP3277683B1/en active Active
- 2016-03-30 ES ES16723536T patent/ES2911886T3/es active Active
- 2016-03-30 US US15/562,381 patent/US10689390B2/en active Active
- 2016-03-30 AU AU2016242473A patent/AU2016242473B2/en active Active
- 2016-03-30 CN CN201680020269.3A patent/CN107548393B/zh active Active
- 2016-03-30 PT PT167235365T patent/PT3277683T/pt unknown
-
2017
- 2017-09-17 IL IL254528A patent/IL254528B/en active IP Right Grant
-
2020
- 2020-05-07 US US16/869,517 patent/US11319326B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11319326B2 (en) | 2022-05-03 |
| JP2018510203A (ja) | 2018-04-12 |
| EP3277683B1 (en) | 2022-03-09 |
| CN107548393B (zh) | 2021-03-02 |
| US10689390B2 (en) | 2020-06-23 |
| RU2017135205A3 (enExample) | 2019-07-17 |
| US20200331926A1 (en) | 2020-10-22 |
| RU2017135205A (ru) | 2019-04-10 |
| EP3277683A1 (en) | 2018-02-07 |
| MX2017012387A (es) | 2018-06-11 |
| NZ735972A (en) | 2024-08-30 |
| CA2980266C (en) | 2025-05-06 |
| BR112017020739A2 (pt) | 2018-07-17 |
| CA2980266A1 (en) | 2016-10-06 |
| JP6764877B2 (ja) | 2020-10-07 |
| CN107548393A (zh) | 2018-01-05 |
| HK1248686A1 (zh) | 2018-10-19 |
| IL254528A0 (en) | 2017-11-30 |
| PL3277683T3 (pl) | 2022-05-23 |
| BR112017020739B1 (pt) | 2023-03-14 |
| AU2016242473B2 (en) | 2020-06-25 |
| ES2911886T3 (es) | 2022-05-23 |
| RU2721120C2 (ru) | 2020-05-15 |
| DK3277683T3 (en) | 2022-05-02 |
| AU2016242473A1 (en) | 2017-10-26 |
| KR102588109B1 (ko) | 2023-10-12 |
| WO2016157221A1 (en) | 2016-10-06 |
| PT3277683T (pt) | 2022-06-28 |
| IL254528B (en) | 2020-11-30 |
| KR20170132278A (ko) | 2017-12-01 |
| US20180282345A1 (en) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX382128B (es) | Derivados de piridin-2-ona fusionados triciclicos, y su uso como inhibidores de brd4. | |
| CO2019000386A2 (es) | Compuestos heterocíclicos como inmunomoduladores | |
| PH12019500036A1 (en) | Heterocyclic compound used as fgfr inhibitor | |
| MX382331B (es) | Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3f] isoquinolina útiles en el tratamiento del cáncer. | |
| MX393395B (es) | Derivado de heteroaril[4,3-c]pirimidina-5-amina, método de preparación del mismo y usos médicos del mismo. | |
| PH12018500904A1 (en) | Peptide macrocycles against acinetobacter baumannii | |
| PH12016501440A1 (en) | Novel heterocyclic compounds | |
| MX379110B (es) | Derivados de azaspiro como antagonistas de trpm8. | |
| MX2018003432A (es) | Compuestos heterociclicos y usos de los mismos. | |
| WO2015058126A8 (en) | Heteroaromatic compounds useful for the treatment of prolferative diseases | |
| WO2015058163A3 (en) | Heteromaromatic compounds useful for the treatment of prolferative diseases | |
| PH12016501355A1 (en) | Bicyclic heterocyclic derivatives as bromodomain inhibitors | |
| MX390747B (es) | Compuesto heterociclico sustituido con alquinilo, su metodo de preparacion y su uso medico. | |
| MX2016016530A (es) | Inhibidores de fosfatidilinositol 3-quinasa. | |
| WO2015191754A3 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| SA519402103B1 (ar) | 1,6-naphthyridine مشتقات 1، 6 نفثيرايدين CDK4/6 على شكل مثبط | |
| DOP2015000214A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| EA201692557A1 (ru) | Хинолизиноновые производные в качестве ингибиторов pi3k | |
| WO2018083635A3 (en) | Tricyclic heterocyclic derivatives and uses thereof | |
| CO2017005806A2 (es) | Nuevos derivados de bencimidazol como agentes antihistamínicos | |
| MX2019006612A (es) | Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta). | |
| MX2017012387A (es) | Derivados fusionados triciclicos de 1-(ciclo)alquil piridin-2-ona utiles para el tratamiento de cancer. | |
| MX2018014165A (es) | Compuestos heterociclicos utiles como agentes antibacterianos y metodo de produccion. | |
| MX2021007032A (es) | Derivados activos de éster de testosterona, composiciones y usos de los mismos. | |
| MX2019000276A (es) | Nuevos derivados ciclopropílicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |